Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Stoke Therapeutics Inc buy Wedbush

Start price
€9.30
26.03.24 / 50%
Target price
€15.67
26.03.25
Performance (%)
15.05%
Price
€10.60
22.04.24
Summary
This prediction is currently active. The prediction currently has a performance of 15.05%. This prediction currently runs until 26.03.25. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Stoke Therapeutics Inc -3.636% -3.636%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by Wedbush for this prediction

In the thread Stoke Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 15.05%
Target price 15.672
Change
Ends at 26.03.25

Stoke Therapeutics, Inc. (NASDAQ: STOK) had its price target raised by analysts at Wedbush from $13.00 to $17.00. They now have an "outperform" rating on the stock.
Ratings data for STOK provided by MarketBeat